Altimmune, Inc. (ALT)
3.155
-0.04
(-1.41%)
USD |
NASDAQ |
Aug 26, 16:00
3.16
0.00 (0.00%)
After-Hours: 20:00
Altimmune Price : 3.155 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 3.14 | 3.225 | 3.11 | 3.20 | 3.820M |
| Aug 24, 2026 | 3.13 | 3.13 | 3.025 | 3.11 | 2.725M |
| Aug 21, 2026 | 2.98 | 3.24 | 2.95 | 3.11 | 6.157M |
| Aug 20, 2026 | 3.07 | 3.08 | 2.92 | 2.95 | 4.681M |
| Aug 19, 2026 | 3.04 | 3.20 | 3.005 | 3.12 | 10.82M |
| Aug 18, 2026 | 2.99 | 3.03 | 2.96 | 2.97 | 2.472M |
| Aug 17, 2026 | 2.94 | 3.02 | 2.90 | 3.00 | 4.057M |
| Aug 14, 2026 | 2.95 | 2.97 | 2.86 | 2.94 | 3.074M |
| Aug 13, 2026 | 2.95 | 2.96 | 2.84 | 2.88 | 4.109M |
| Aug 12, 2026 | 3.05 | 3.20 | 2.92 | 2.93 | 6.046M |
| Aug 11, 2026 | 3.06 | 3.08 | 2.98 | 3.00 | 3.635M |
| Aug 10, 2026 | 3.09 | 3.10 | 2.99 | 3.05 | 5.260M |
| Aug 07, 2026 | 3.05 | 3.10 | 3.00 | 3.08 | 4.506M |
| Aug 06, 2026 | 3.03 | 3.05 | 2.95 | 3.01 | 3.977M |
| Aug 05, 2026 | 3.07 | 3.12 | 3.005 | 3.03 | 3.164M |
| Aug 04, 2026 | 3.01 | 3.08 | 2.95 | 3.07 | 8.163M |
| Aug 03, 2026 | 2.882 | 3.025 | 2.855 | 3.00 | 4.647M |
| Jul 31, 2026 | 2.99 | 2.99 | 2.78 | 2.84 | 3.892M |
| Jul 30, 2026 | 2.925 | 3.005 | 2.86 | 2.98 | 5.439M |
| Jul 29, 2026 | 3.00 | 3.10 | 2.895 | 2.92 | 8.301M |
| Jul 28, 2026 | 3.162 | 3.31 | 2.815 | 2.99 | 17.14M |
| Jul 27, 2026 | 2.80 | 3.03 | 2.80 | 2.96 | 4.060M |
| Jul 24, 2026 | 2.85 | 2.889 | 2.76 | 2.77 | 1.912M |
| Jul 23, 2026 | 2.79 | 2.84 | 2.75 | 2.84 | 1.626M |
| Jul 22, 2026 | 2.81 | 2.865 | 2.765 | 2.81 | 2.291M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 440.30 |
| Protalix Biotherapeutics, Inc. | 2.475 |
| Taysha Gene Therapies, Inc. | 6.015 |
| Humacyte, Inc. | 0.6852 |
| Liquidia Corp. | 71.36 |
Price Related Metrics
| PS Ratio | 12720.17 |
| Price to Book Value | 1.294 |
| Earnings Yield | -25.00% |
| Market Cap | 613.57M |